Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3829

Sort by

Sort Order Select

Journal Articles

Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease

Yunfeng Liu, Mouli Pal, Weili Bao, Patricia A. Shi, Cheryl A. Lobo, Xiuli An, Deepa Manwani, Hui Zhong, Karina Yazdanbakhsh

Blood (2021) 138 (13): 1162–1171.

https://doi.org/10.1182/blood.2021011629

Published: 2021

Includes: Supplemental data

Journal Articles

Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin

Eric R. Henry, Belhu Metaferia, Quan Li, Julia Harper, Robert B. Best, Kristen E. Glass, Troy Cellmer, Emily B. Dunkelberger, Anna Conrey, Swee Lay Thein, H. Franklin Bunn, William A. Eaton

Blood (2021) 138 (13): 1172–1181.

https://doi.org/10.1182/blood.2021012070

Published: 2021

Includes: Supplemental data

Journal Articles

Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither

Richard J. Jones, Michael R. DeBaun

Blood (2021) 138 (11): 942–947.

https://doi.org/10.1182/blood.2021011488

Published: 2021

Journal Articles

Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia

Catherine M. Bollard

Blood (2021) 138 (11): 913.

https://doi.org/10.1182/blood.2021012891

Published: 2021

Journal Articles

Gene therapy for sickle cell disease: moving from the bench to the bedside

Allistair A. Abraham, John F. Tisdale

Blood (2021) 138 (11): 932–941.

https://doi.org/10.1182/blood.2019003776

Published: 2021

Journal Articles

Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease

Blood (2021) 137 (22): 3116–3126.

https://doi.org/10.1182/blood.2020009063

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Minke A. E. Rab, Jennifer Bos, Brigitte A. van Oirschot, Stephanie van Straaten, Penelope A. Kosinski, Victor Chubukov, Hyeryun Kim, Heidi Mangus, Roger E. G. Schutgens, Gerard Pasterkamp, Lenny Dang, Charles Kung, Eduard J. van Beers, Richard van Wijk

Blood (2021) 137 (21): 2997–3001.

https://doi.org/10.1182/blood.2020008635

Published: 2021

Includes: Supplemental data

Journal Articles

P-selectin and sickle cell disease: a balancing act

Deepa Manwani

Blood (2021) 137 (19): 2573–2574.

https://doi.org/10.1182/blood.2021011151

Published: 2021

Journal Articles

P-selectin deficiency promotes liver senescence in sickle cell disease mice

Ravi Vats, Tomasz W. Kaminski, Eun-Mi Ju, Tomasz Brozska, Egemen Tutuncuoglu, Jesús Tejero, Enrico M. Novelli, Prithu Sundd, Tirthadipa Pradhan-Sundd

Blood (2021) 137 (19): 2676–2680.

https://doi.org/10.1182/blood.2020009779

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers

Debra D. Pittman, Patrick C. Hines, David Beidler, Denis Rybin, Andrew L. Frelinger, III, Alan D. Michelson, Ke Liu, Xiufeng Gao, Jennell White, Ahmar U. Zaidi, Robert J. Charnigo, Michael U. Callaghan

Blood (2021) 137 (15): 2010–2020.

https://doi.org/10.1182/blood.2020006020

Published: 2021

Includes: Supplemental data

Journal Articles

Less (Fe) is more (Hb) in SCA

Carlo Brugnara

Blood (2021) 137 (11): 1446–1447.

https://doi.org/10.1182/blood.2020010131

Published: 2021

Journal Articles

Dietary iron restriction improves markers of disease severity in murine sickle cell anemia

Nermi L. Parrow, Pierre-Christian Violet, Nisha Ajit George, Faris Ali, Shivam Bhanvadia, Ryan Wong, John F. Tisdale, Courtney Fitzhugh, Mark Levine, Swee Lay Thein, Robert E. Fleming

Blood (2021) 137 (11): 1553–1555.

https://doi.org/10.1182/blood.2020006919

Published: 2021

Includes: Supplemental data

Journal Articles

Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease

Junaid Ansari, Elena Y. Senchenkova, Shantel A. Vital, Zaki Al-Yafeai, Gaganpreet Kaur, Erica M. Sparkenbaugh, A. Wayne Orr, Rafal Pawlinski, Robert P. Hebbel, D. Neil Granger, Paul Kubes, Felicity N. E. Gavins

Blood (2021) 137 (11): 1538–1549.

https://doi.org/10.1182/blood.2020009166

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Sickle cell disease, interleukin-18, and arrhythmias

Pavel Zhabyeyev, Gavin Y. Oudit

Blood (2021) 137 (9): 1138–1139.

https://doi.org/10.1182/blood.2020009690

Published: 2021

Journal Articles

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Blood (2021) 137 (6): 856–859.

https://doi.org/10.1182/blood.2020008146

Published: 2021

Includes: Supplemental data

Journal Articles

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

L. Joseph, C. Jean, S. Manceau, C. Chalas, C. Arnaud, A. Kamdem, C. Pondarré, A. Habibi, F. Bernaudin, S. Allali, M. de Montalembert, B. Boutonnat-Faucher, J.-B. Arlet, B. Koehl, M. Cavazzana, J.-A. Ribeil, F. Lionnet, I. Berthaut, V. Brousse

Blood (2021) 137 (6): 826–829.

https://doi.org/10.1182/blood.2020006270

Published: 2021

Journal Articles

Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain

Claudia R. Morris, Lou Ann S. Brown, Michael Reynolds, Carlton D. Dampier, Peter A. Lane, Amanda Watt, Polly Kumari, Frank Harris, Shaminy Manoranjithan, Reshika D. Mendis, Janet Figueroa, Sruti Shiva

Blood (2020) 136 (12): 1402–1406.

https://doi.org/10.1182/blood.2019003672

Published: 2020

Includes: Supplemental data

Journal Articles

Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease

Saranya Veluswamy, Payal Shah, Maha Khaleel, Wanwara Thuptimdang, Patjanaporn Chalacheva, John Sunwoo, Christopher C. Denton, Roberta Kato, Jon Detterich, John C. Wood, Richard Sposto, Michael C. K. Khoo, Lonnie Zeltzer, Thomas D. Coates

Blood (2020) 136 (10): 1191–1200.

https://doi.org/10.1182/blood.2020005045

Published: 2020

Includes: Supplemental data

Journal Articles

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Ruta Brazauskas, Graziana M. Scigliuolo, Hai-Lin Wang, Barbara Cappelli, Annalisa Ruggeri, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J. Meerpohl, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, Mark C. Walters, John E. Wagner, John F. Tisdale, Eliane Gluckman, Mary Eapen

Blood (2020) 136 (5): 623–626.

https://doi.org/10.1182/blood.2020005687

Published: 2020

Includes: Supplemental data

Journal Articles

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties

Yohann Garnier, Séverine Ferdinand, Marie Garnier, Kizzy-Clara Cita, Régine Hierso, Aurélie Claes, Philippe Connes, Marie-Dominique Hardy-Dessources, Claudine Lapouméroulie, Nathalie Lemonne, Maryse Etienne-Julan, Wassim El Nemer, Marc Romana

Blood (2020) 136 (2): 247–256.

https://doi.org/10.1182/blood.2020004853

Published: 2020

Includes: Supplemental data

NARROW

Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease

Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin

Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither

Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia

Gene therapy for sickle cell disease: moving from the bench to the bedside

Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

P-selectin and sickle cell disease: a balancing act

P-selectin deficiency promotes liver senescence in sickle cell disease mice

Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers

Less (Fe) is more (Hb) in SCA

Dietary iron restriction improves markers of disease severity in murine sickle cell anemia

Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease

Sickle cell disease, interleukin-18, and arrhythmias

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain

Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only